-
Details
-
Written by Mahmood Nekoei-Moghadam, Mohammadreza Amiresmaili
-
Parent Category: Year 2012, Volume 4
-
Category: Year 2012, Volume 4, Issue 3, September-December 2012
-
Hits: 4383
Introduction: Healthcare as a high hazard industry, should work to enhance their patient safety. To achieve this objective, they first have to identify their existing safety climate status.
Methods: This study was conducted in summer of 2010. We assessed safety climate Using Hospital Survey On Patient Safety Culture (HSOPSC). 385 employees of three teaching hospitals affiliated with Kerman University of Medical Sciences participated in the study. The results were expressed as percentage of positive answers toward patient safety.
Results: Patient safety culture scores were low to average in all dimensions. Supervisor expectations and actions promoting patient safety and teamwork within units received the highest scores in all three hospitals, while non punitive response to error attained the least score in studied hospitals.
Conclusion: The studied hospitals, relying on their strengths concerning patient’s safety climate and trying to resolve their weaknesses, would be able to create a safe and suitable environment which supports patient safety. Establishing a system for reporting errors, encouraging staff to report events and applying non- punitive response to prevent the errors are suggested..
Key words: Patient’s safety; Safety climate; Safety culture
ファッションコーディネートnike air make plus blue color chart lularoe
The most recent editorial (June 2021)
Ethics of Publishing Case Reports: Do We Need Ethics Approval and Patient Consent?
An editorial by Dr. Mehrdad Jalalian
Read more.
The worldwide spread of COVID-19 as an emerging, rapidly evolving situation, and the dramatic need of urgent medicine or vaccine, has rapidly brought new hypotheses for pathophysiology and potential medicinal agents to the fore. It is crucial that the research community provide a way to publish this research in a timely manner.
To contribute to this important public health discussion, the Electronic Physician Journal is excited to announce a fast-track procedure to help researchers publish their articles on COVID-19 related subjects that fall under the broad definition of public health, internal medicine, and pharmacology. We are especially welcome to all hypotheses about the pathological basis of the COVID-19 infection and the possible characteristics of potential medicine and vaccine. Submit your manuscript here
Our previous editorial (June 2020)
Lessons from COVID-19 pandemic and the Morocco’s success story.
An editorial by Dr. Benksim Abdelhafid (Morocco)
Read more.
The 6th World Conference on Research Integrity (WCRI) is to be held on June 2-5, 2019 in Hong Kong.
The WCRI is the largest and most significant international conference on research integrity. Since the first conference in Lisbon in 2007, it has given researchers, teachers, funding agencies, government officials, journal editors, senior administrators, and research students opportunities to share experiences and to discuss and promote integrity in research. Read more:
TDR Clinical Research and Development Fellowships
Call for applications
Deadline for submission: 7 March 2019, 16:00 (GMT)
TDR provides fellowships for early- to mid-career researchers and clinical trial staff (e.g. clinicians, pharmacists, medical statisticians, data managers, other health researchers) in low- and middle-income countries (LMICs) to learn how to conduct clinical trials. Read more:
Meta-Analysis Workshops in New York, USA, and London, UK, in April and May 2019
Don't miss this exceptional opportunity to learn how to perform and report a Meta-analysis correctly. Two Meta-analysis workshops are organized in April and May 2019 by Dr. Michael Borenstein in New York, USA (April 08-10, 2019) and London, UK (May 27-29).
About the Instructor
Dr. Michael Borenstein, one of the authors of Introduction to Meta-Analysis, is widely recognized for his ability to make statistical concepts accessible to researchers as well as to statisticians. He has lectured widely on meta-analysis, including at the NIH, CDC, and FDA. Read more:
